Differential Control of iNKT Cell Effector Lineage Differentiation by the Forkhead Box Protein O1 (Foxo1) Transcription Factor
The invariant NKT ( i NKT) cells recognize glycolipid antigens presented by the non-classical MHC like molecule CD1d. They represent an innate T-cell lineage with the ability to rapidly produce a variety of cytokines in response to agonist stimulation to bridge innate and adaptive immunity. In thymu...
Saved in:
Published in | Frontiers in immunology Vol. 10; p. 2710 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
21.11.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invariant NKT (
i
NKT) cells recognize glycolipid antigens presented by the non-classical MHC like molecule CD1d. They represent an innate T-cell lineage with the ability to rapidly produce a variety of cytokines in response to agonist stimulation to bridge innate and adaptive immunity. In thymus, most
i
NKT cells complete their maturation and differentiate to multiple effector lineages such as
i
NKT-1,
i
NKT-2, and
i
NKT-17 cells that possess the capability to produce IFNγ, IL-4, and IL-17A, respectively, and play distinct roles in immune responses and diseases. Mechanisms that control
i
NKT lineage fate decisions are still not well understood. Evidence has revealed critical roles of Foxo1 of the forkhead box O1 subfamily of transcription factors in the immune system. However, its role in
i
NKT cells has been unknown. In this report, we demonstrate that deletion of Foxo1 causes severe decreases of
i
NKT cell total numbers due to impairment of late but not early
i
NKT cell development. Deficiency of Foxo1 results in decreases of
i
NKT-1 but increases of
i
NKT-17 cells. Our data reveal that Foxo1 controls
i
NKT effector lineage fate decision by promoting
i
NKT-1 but suppressing
i
NKT-17 lineages. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Yun-Cai Liu, Tsinghua University, China Reviewed by: Jinfang Zhu, National Institute of Allergy and Infectious Diseases (NIAID), United States; Koji Yasutomo, Tokushima University, Japan This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2019.02710 |